Editorial Board
136 Editors in 18 Countries/Regions
Editor-in-Chief
Guangwen Cao
gcao@smmu.edu.cnChairman, Professor, and PhD Supervisor at Department of Epidemiology, Second Military Medical University, Shanghai, China.
Research Interests: hepatitis B virus, hepatocellular carcinoma, evolution, prediction, prophylaxis, therapeutic option, predicative biomarker, prognostic biomarkers
Executive Chief Editor
Giuliano Ramadori
Professor of Medicine, Gastroenterology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany.
Research Interests: gene expression, liver cells (hepatocytes, kupffer cells, endothelial cells, stellate cells), pathogenesis, inflammation, cancer development, animal models of liver cancer diagnostic procedures and therapy, COVID-19 diagnostic and treatment, mechanisms of acute-phaseresponse, gastrointestinal cancer diagnostic and endoscopic therapy, systemic cancer therapy, tumor microenviroment analysis, liver diseases diagnostic, therapy, iron metabolism, radiation biology
Honorary Editors-in-Chief
Masao Omata
Department of Gastroenterology, University of Tokyo, Tokyo, Japan.
Research Interests: hepatology, gastroenterology, oncology
Shu-Kui Qin
Clinical Oncology Department, Nanjing Jinling Hospital, Nanjing, Jiangsu, China.
Research Interests: gastrointestinal cancers, treatment, liver cancer, primary liver cancer
Associate Chief Editors
Patrizia Burra
Gastroenterology Unit and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, University Hospital of Padua, Italy.
Research Interests: liver transplantation (HBV prophylaxis after transplantation, liver transplantation for MAFLD and MASH, frailty and obesity, early liver transplantation for acute alcoholic hepatitis), hepatocellular carcinoma, primary sclerosing cholangitis, cholangiocarcinoma
Francesco De Cobelli
Department of Radiology, IRCCS San Raffaele Hospital, Milan, Italy.
Research Interests: characterization of oncological imaging, interventional oncology, heptobiliary locoregional treatments, hepatocellular carcinoma, cholangiocarcinoma
Jia Fan
Department of Liver Surgery, Fudan University, Shanghai, China.
Research Interests: hepatocellular carcinoma, clinical diagnosis, treatment and basic research of liver cancer
Fabio Farinati
Department of Surgical and Gastroenterological Sciences, Padua University, Padua, Italy.
Research Interests: hepatocellular carcinoma, precision medicine, non-alcoholic steatohepatitis, microRNA, locoregional treatments
Guido Gerken
Department of Gastroenterology and Hepatology, University of Essen, Essen, Germany.
Research Interests: internal medicine, gastroenterology, hepatology, clinical virology, clinical immunology, endoscopy, liver transplantation, autoimmunity, infectiology, visceral medicine, acute and terminal liver failure, molecular pathomechanisms of liver failure, fibrosis progression of chronic liver diseases, evaluation of mini-laparoscopy for the diagnosis of chronic liver diseases, crohn’s disease, ulcerative colitis, autoimmune hepatitis, viral hepatitis and HIV coinfection, hepatocellular carcinoma, establishment of biomarkers in gastroenterology
Salvatore Gruttadauria
Department of Surgery, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (IRCCS-ISMETT), Palermo, Italy.
Research Interests: liver resection, liver transplantation, laparoscopic surgery, laparoscopic thermal ablation, living related liver transplantation, living donor
Nuh Rahbari
Department of General and Visceral Surgery, Ulm University Hospital, Ulm, Germany.
Research Interests: hepatectomy, minimally invasive surgery, hepatocellular carcinoma, immunotherapy
Feng Shen
Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
Research Interests: intrahepatic cholangiocarcinoma, treatment of hepatobiliary and pancreatic diseases
Claudio Tiribelli
Fondazione Italiana Fegato – Italian Liver Foundation NPO, AREA Science Park, Trieste, Italy.
Research Interests: bilirubin, neonatal jaundice, metabolic liver diseases, hepatocellular carcinoma, stem cells in hepatocellular carcinoma, crigler-najjar syndrome, translational medicine
Georgios Tsoulfas
Surgery, Aristoteleion University of Thessaloniki, Thessaloniki, Greece.
Research Interests: hepatobiliary surgery, primary and secondary hepatic malignancies, ischemia/reperfusion injury, solid organ transplantation, medical/surgical education, 3D printing
Sudhakar K. Venkatesh
Abdominal Imaging Division, Department of Radiology, Mayo Clinic, Rochester, MN, USA.
Research Interests: liver fibrosis, chronic liver disease, autoimmune liver diseases, hepatocellular carcinoma, cholangiocarcinoma
Kai-Chun Wu
Emergency Room of Digestive Diseases, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Xi'an, Shaanxi, China.
Research Interests: gastrointestinal cancers, treatment, liver cancer, gut
Editorial Board Members
Luca Aldrighetti
Hepatobiliary and General Surgery Division, San Raffaele Hospital, Milan, Italy.
Research Interests: surgical treatment of hepatobiliary diseases, minimally invasive surgery, resection, cholangiocarcinoma
Anna Alisi
Research Unit of Molecular Genetics of Complex Phenotypes, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Research Interests: non-alcoholic fatty liver disease, cirrhosis
Francesco Ardito
Hepatobiliary Surgery Unit, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.
Research Interests: minimally invasive liver surgery, liver resection for malignant and benign hepatobiliary disease, hepatocellular carcinoma, cholangiocarcinoma, liver metastases
Matías A Avila
Hepatology Program, Centre for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
Research Interests: molecular mechanisms, carcinogenesis, liver regeneration, liver fibrosis, chronic liver diseases
Clara Balsano
Internal Medicine (MED 09), Department of Life, Health and Environmental Sciences (MESVA), University of L'Aquila, L'Aquila, Italy.
Research Interests: new immunological treatments, autoimmune hepatitis, role of hepatitis B virus and hepatitis B virus viral proteins in tissue damage, biomarkers, nonalcoholic fatty liver disease, steatohepatitis, gender differences, response, innovative treatments
Irene Bargellini
Department of Surgical Sciences, University of Turin, Turin, Italy; Diagnostic and Interventional Radiology Department, Candiolo Cancer, Institute, IRCCS, FPO, Candiolo, Italy.
Research Interests: loco-regional treatments of liver tumors, ablation, transaterial chemoembolization, transarterial readioembolization, imaging response criteria
Eliza Wright Beal
Departments of Surgery and Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA.
Research Interests: surveillance for hepatocellular carcinoma, treatment of hepatocellular carcinoma, hepatitis B virus, hepatitis C virus, cirrhosis, minimally invasive hepatectomy, systemic cancer therapy, intrahepatic cholangiocarcinoma
Stefano Bellentani
Gastroenterology and Hepatology Service, Clinica Santa Chiara, Locarno, Switzerland.
Research Interests: metabolic associated fatty liver disease, non-alcoholic fatty liver disease, endocrine disorders, sex differences, metabolic syndrome, liver, hypobetalipoproteinemia, dysmetabolism in hepatitis C virus
Andrea Belli
Department of Abdominal Oncology, HPB Surgical Oncology, National Cancer Institute - G. Pascale - IRCCS, Naples, Italy.
Research Interests: liver resection, minimally invasive surgery, robotic surgery, hepatocellular carcinoma, cholangiocarcinoma
Antonio Benedetti
Clinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Università Politecnica delle Marche, Ancona, Italy.
Research Interests: cholangiocarcinoma, hepatocellular carcinoma, immunotherapy
Antonio Bertoletti
Division Emerging Infectious Diseases, Duke-NUS Graduate Medical School, Singapore City, Singapore.
Research Interests: immunopathogenesis, hepatitis C virus infection, SARS-CoV1/2 infections, new immunological based therapies (T cell receptor-redirected T cells), treatment of hepatitis C virus, SARS-CoV-2, hepatocellular carcinoma
Giovanni Brandi
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Division of Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Research Interests: cholangiocarcinoma, hepatocellular carcinoma, hepatobiliary pancreatic tumors, cancer risk factors, target therapies, predictive oncological biomarkers, microbiota, hydrogen therapy in cancer
Stefano Brillanti
Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
Research Interests: hepatocellular carcinoma, hepatitis B/C virus, cirrhosis, non-alcoholic steatohepatitis
Elisa Callegari
Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.
Research Interests: hepatocellular carcinoma, cirrhosis, transgenic mice, micro RNA, therapy, prophylaxis, liquid biopsies
Isabelle Chemin
INSERM, Hepatology Institute Lyon, Lyon, France.
Research Interests: hepatitis B, hepatitis delta, hepatocellular carcinoma, animal models, aflatoxin B1, variants, occult hepatitis B
Jian-Guo Chen
Qidong Liver Cancer Institute, Tumor Institute, Tumor Hospital, Nantong University, Nantong, Jiangsu, China.
Research Interests: hepatitis B virus, prevention, HBsAg, survival
Xiangmei Chen
Department of Microbiology & Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing, China.
Research Interests: pathogenesis of HBV-related HCC, molecular mechanism of HBV replication and pathogenesis
William C Cho
Department of Clinical Oncology, Queen Elizabeth Hospital Hong Kong, Hong Kong, China.
Research Interests: cancer biomarkers, genomics, proteomics, non-coding RNA, drug repurposing
Kenneth Siu Ho Chok
Department of Surgery, University of Hong Kong, Hongkong, China.
Research Interests: hepatocellular carcinoma, liver transplantation, intrahepatic cholangiocarcinoma
Evangelos Cholongitas
First Department of Internal Medicine, "Laiko" General Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece.
Research Interests: cirrhosis, liver transplantation, NAFLD, hepatocellular carcinoma
Umberto Cillo
Department of Surgery, Oncology and Gastroenterology, Hepatobiliary Surgery and Liver Transplantation Unit, Padova University Hospital, Padova, Italy.
Research Interests: hepatobiliary surgery, liver surgery, liver cancer surgery, gastrointestinal surgical oncology, orthotopic liver transplantation, living donor liver transplantation, pediatric liver transplantation
Valli De Re
Immunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano (CRO), Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
Research Interests: HCV, molecular pathogenesis, biomarkers, hepatocellular carcinoma
Paolo De Simone
Hepatobiliary surgery and liver transplantation, University of Pisa Medical School Hospital, Pisa, Italy.
Research Interests: liver transplant, liver surgery, liver malignancy, hepatocellular carcinoma, donor surgery
Renumathy Dhanasekaran
Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA.
Research Interests: liver cancer, HCC, tumor progression, cancer immunology, macrophages
Marcello Di Martino
Department of Hepatobiliary and Liver Transplant Surgery, A.O.R.N. Cardarelli, Naples, Italy.
Research Interests: hepatocellular carcinoma, liver metastasis, liver cirrhosis, liver imaging, liver resection
Hui-Guo Ding
Department of Gastroenterology and Hepatology, Beijing You An Hospital affiliated to Capital Medical University, Beijing, China.
Research Interests: clinical diagnosis, treatment and research of liver cirrhosis, portal hypertension and its complications, early liver cancer diagnosis and screening, ascites, gastrointestinal bleeding, malnutrition, hepatic encephalopathy, pancreatic biliary disease, endoscopic minimally invasive diagnosis and treatment
Jin Ding
Clinical Cancer Institute, Center for Translational Medicine, Naval Medical University, Shanghai 200433, China.
Research Interests: liver cancer stem cell, targeted drug resistance, differentiation therapy
Matteo Donadon
Division of Surgical Oncology, Department of Surgery, University Maggiore Hospital della Carità, Novara, Italy.
Research Interests: surgical oncology of hepatobiliary and pancreatic diseases, surgical techniques, mininvasive approaches, surgical outcomes measures, hepatocellular carcinoma, cholangiocarcinoma, systemic treatments, translational research
Jean-François Dufour
Centre for Digestive Diseases, Lausanne, Switzerland.
Research Interests: MASLD, MASH, hepatocellular carcinoma
Hirayuki Enomoto
Division of Hepatobiliary and Pancreatic Diseases, Department of Gastroenterology, Hyogo Medical University, Nishinomiya, Hyogo, Japan.
Research Interests: hepatitis B virus, hepatitis C virus, liver cirrhosis, hepatocellular carcinoma
Isabel Fabregat
Bellvitge Biomedical Research Institute (IDIBELL), CIBEREHD and University of Barcelona, L’Hospitalet, Barcelona, Spain.
Research Interests: liver cancer, hepatocellular carcinoma, liver fibrosis, liver regeneration, TGF-beta, EGF, NADP hoxidases, NOX4, oxidative stress
Antonio Facciorusso
Section of Gastroenterology, Department of Medical Sciences, University of Foggia, Foggia, Italy.
Research Interests: HCC, portal hypertension, ablative treatments, TACE, radioembolization
Jiangao Fan
Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Research Interests: fatty liver, non-alcoholic liver disease, metabolic syndrome, obesity, type 2 diabetes, hepatocellular carcinoma
Lynn G. Feun
Department of Medicine, University of Miami, Miller School of Medicine, Miami, FL, USA.
Research Interests: hepatocellular carcinoma, biomarkers, clinical trials, immunotherapy
Richard S. Finn
Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Research Interests: molecular therapies for hepatocellular carcinoma, systemic therapy, therapeutic strategies
Georgios Germanidis
First Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Research Interests: HCC immunology, new ICI targets and strategies for neo/and or adjuvant HCC treatment, HCC microenvironment, new serum, plasma or biopsy and peripheral whole blood prognostic and predictive markers
Brian Kim Poh Goh
Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore.
Research Interests: laparoscopic surgery, robotic surgery, liver resection, prognostication, hepatocellular carcinoma
Alessandro Granito
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Research Interests: autoimmune liver diseases, autoimmune hepatitis, autoimmune cirrhosis, hepatocellular carcinoma, cancer immunotherapy, cancer immunotherapy related adverse events
Ho-Seong Han
Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, South Korea.
Research Interests: hepatobiliary-pancreatic surgery, hepatocellular carcinoma, pancreas cancer, biliary tract cancer
Minimally invasive surgery for gallbladder cancer at an expert center
Minimally invasive surgery for HCC
The role of minimally invasive surgery in the treatment of HCC
Michael A. Heneghan
Institute of Liver Studies, King's College Hospital, Denmark Hill, London, UK.
Research Interests: autoimmune hepatitis, liver transplant, acute liver failure, primary biliary cholangitis
Mitchell Ho
Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Research Interests: immunotherapy, tumor antigens, hepatocellular carcinoma, cholangiocarcinoma
Jin-Lin Hou
Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Research Interests: clinical management of viral hepatitis, molecular virology, immunology of hepatitis B virus (HBV), severe acute respiratory syndrome (SARS) infection
Jianfei Huang
Clinical biobank and Oncology, Clinical and Translational Research Center & Institute of Oncology, Nantong University Affiliated Hospital, Nantong, Jiangsu, China.
Research Interests: oncology, tumor microenvironment, tumor markers, translational research, hepatocellular carcinoma
Teh-Ia Huo
Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan;
Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital, Taipei, Taiwan.
Research Interests: liver cancer, liver cirrhosis, viral hepatitis
Roberto Iezzi
Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Research Interests: interventional oncology, hepatobiliary locoregional treatments, hepatocellular carcinoma, cholangiocarcinoma, colorectal metastases, ablation, chemoembolization, radioembolization, technical innovation
David K Imagawa
Department of Surgery, Irvine Medical Center, University of California, Orange, CA, USA.
Research Interests: bile duct cancer, liver cancer, treatment of bile duct injuries, chemoembolization, hemostatic agents
Toru Ishikawa
Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
Research Interests: hepatocellular carcinoma, portal hypertension, interventional radiology
Francesco Izzo
Hepatobiliary and Pancreatic Surgery Unit, National Cancer Institue, IRCCS Fondazione "G. Pascale", Napoli, Italy.
Research Interests: surgical treatment of hepatobiliary and pancreatic diseases, minimally invasive surgery, locoregional treatment
Jeong Won Jang
Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
Research Interests: hepatocellular carcinoma, hepatitis B, HBV carcinogenesis, biomarkers, prevention and management
Milind Javle
Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Research Interests: cholangiocarcinoma, biliary tract cancer
De-Ke Jiang
State Key Laboratory of Organ Failure Research, Guangdong Key Laboratory of Viral Hepatitis Research, Institutes of Liver Diseases Research of Guangdong Province, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Research Interests: genetic epidemiology, epigenetics, pharmacogenomics, molecular mechanism, chronic hepatitis B, hepatocellular carcinoma
Tatsuo Kanda
Department of Gastroenterology and Hepatology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Minamiuonuma, Japan;
Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
Research Interests: liver cancer, immune related adverse events, HBV reactivation and viral hepatitis
Thomas Kietzmann
Faculty of Biochemistry and Molecular Medicine, University of Oulu, Biocenter Oulu, Oulu, Finland.
Research Interests: hypoxia, reactive oxygen species (ROS) Cancer, liver metabolism and zonation, cell signaling and transcriptional regulation, hemostasis and fibrinolysis, obesity and diabetes, insulin signaling, protein structure and stability
Jin-Wook Kim
Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
Research Interests: viral hepatitis B and C, molecular biology, new drugs, clinical trials, liver fibrosis, liver cancer, pathogenesis, treatment
John S. Koskinas
Medical School National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.
Research Interests: hepatocellular carcinoma, hepatitis B virus, hepatitis C virus, liver cirrhosis
Sandi A. Kwee
John A. Burns School of Medicine, University of Hawaii at Manoa, HI, USA.
Research Interests: molecular imaging, liquid biopsy, hepatocellular carcinoma biomarkers, immunotherapy, chronic liver disease
Edward Wolfgang Lee
Ronald Reagan UCLA Medical Center, Los Angeles, USA.
Research Interests: hepatocellular carcinoma, cholangiocarcinoma, interventional oncology, tumor ablation, radioembolization, portal hypertension, TIPS, RTO, liver lymphatics, biliary intervention
Ju-Seog Lee
Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Research Interests: genomics, biomarkers, HCC
Terence Kin Wah Lee
Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hong Kong, China.
Research Interests: cancer stem cells, gut microbiota, therapeutic resistance, cancer immunology, hepatocellular carcinoma
Riccardo Lencioni
Cancer Imaging Program, Pisa University School of Medicine, Pisa, Italy.
Research Interests: imaging of liver tumors, loco-regional and systemic therapies for hepatocellular carcinoma, response evaluation criteria (RECIST and mRECIST)
Jan Lerut
Starzl Unit Abdominal Transplantation, University Hospitals Saint Luc, Université catholique Louvain, UCL Brussels, Brussels, Belgium.
Research Interests: transplantation oncology, immunosuppression and tolerance induction in liver transplantation, collaboration between East and Western surgical transplantation worlds
Nan Li
Department of Hepatic Surgery VI, AnTing District of the Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
Research Interests: hepatocellular carcinoma, HBV-DNA, metastasis, transformation, liver transplantation
Tingbo Liang
Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Research Interests: hepatobiliary and pancreatic surgery, organ transplantation, tumor immunity, hepatocellular carcinoma
David M. Liu
Division of Interventional Radiology, Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada.
Research Interests: radiomics, intraoperative molecular imaging, ablation, embolization, HCC, cholangiocarcinoma, hepatic metastatic disease, liver regeneration
Lianxin Liu
Department of Hepatobiliary Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Anhui Provincial Clinical Research Center for Hepatobiliary Diseases, Hefei, Anhui, China.
Research Interests: hepatocellular carcinoma, cholangiocarcinoma, surgery, immunotherapy, liver cancer
Amedeo Lonardo
Operating Unit of Metabolic Syndrome, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, Modena, Italy.
Research Interests: metabolic associated fatty liver disease, non-alcoholic fatty liver disease, endocrine disorders, sex differences in non-alcoholic fatty liver disease, metabolic syndrome, liver, hypobetalipoproteinemia, dysmetabolism in hepatitis C virus infection, diabetes in cirrhosis
Editorial: Metabolism and Target Organ Damage
The Fatty liver Index (FLI) 15 years later: a reappraisal
Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms
Commentary: Of women, liver, and heart
Is liver fibrosis a risk factor for gynecological cancers?
Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review
Copper and liver fibrosis in MASLD: the two-edged sword of copper deficiency and toxicity
Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease
Yinying Lu
Department of Hepatology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Research Interests: hepatocellular carcinoma, immunotherapy, liver tumor
Chun-Hong Ma
School of Basic Medical Science, Shandong University, Jinan, Shandong, China.
Research Interests: immune regulation, liver diseases, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, immunology
David C. Madoff
Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Research Interests: interventional radiology, liver cancer, thermal ablation, embolotherapy, liver regeneration
Amit Mahipal
Department of Oncology, University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH, USA.
Research Interests: liver cancer, hepatocellular cancer, bile duct cancer, cholangiocarcinoma, systemic therapy, immunotherapy, chemotherapy, prognostic and predictive biomarkers, epidemiology
Jose J. G. Marin
Laboratory of Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute for Biomedical Investigation of Salamanca (IBSAL), Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain; National Center for the Study of Liver and Digestive Diseases (CIBEREHD), Carlos III National Institute of Health, Madrid, Spain.
Research Interests: liver cancer, chemoresistance characterization and sensitization, drug targeting, gene therapy strategies
Fabio Marra
Dipartimento di Medicina Sperimentale Clinica, University of Florence, Florence, Italy.
Research Interests: cholangiocarcinoma, liver transplant, non-alcoholic steatohepatitis
Geoffrey Mccaughan
School of Medicine, University of Sydney, Sydney, Australia.
Research Interests: immunopathogenesis, chronic liver disease, liver autoimmunity, liver transplantation, hepatitis B and C virus, hepatocellular carcinoma
Manuela Merli
Department of Translational and Precision medicine, "Sapienza" University of Rome, Rome, Italy.
Research Interests: liver cirrhosis, portal hypertension, hepatic encephalopathy, bacteria infections in chronic liver disease, malnutrition and sarcopenia in liver disease, liver transplantation
Gabriele Missale
Unit of Infectious Diseases and Hepatology, University Hospital of Parma, Parma, Italy.
Research Interests: hepatocellular carcinoma, tumor immune microenvironment, hepatitis B virus, hepatitis C virus, immuneresponse, T cell, NK cell
Bruno Nardo
Department of Medical and Surgical Sciences (DIMEC), S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Research Interests: surgical oncology, hepatobiliary pancreatic surgery, liver transplantation, experimental surgery, liver regeneration
Kelvin K. Ng
Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.
Research Interests: liver cancer, liver transplantation
Matthias Ocker
Medical Department, Division of Hematology, Oncology, and Cancer Immunology, Campus, Charité Mitte, Charité University Medicine Berlin, Berlin, Germany.
Research Interests: drug discovery and development, precision medicine for HCC and CCA, cell death pathways, early clinical trials, biomarkers
Peng Jin London Lucien Ooi
Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore.
Research Interests: surgery and surgical oncology, hepato-pancreato-biliary, transplant surgery
Necati Örmeci
Department of Gastroenterology, Ankara University Medical School, Ankara, Turkey.
Research Interests: hepatitis B virus, hepatitis C virus, hepatitis D virus, hepatocellular carcinoma, hydatidCyst, portal hypertension
Valérie Paradis
Pathology Department, Hôpital Beaujon, AP-HP, Clichy, France.
Research Interests: liver tumors, tumor heterogeneity, molecular imaging, preneoplastic liver lesions
Young Nyun Park
Department of Pathology, Graduate School of Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
Research Interests: hepatocellular carcinoma, liver diseases, liver cirrhosis, cholangiocarcinoma, liver failure
Rosa Maria Pascale
Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
Research Interests: hepatocarcinogenesis, model, genes alterations, signal transductions, targeting therapy
Tao Peng
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Research Interests: hepatocellular carcinoma, biomarkers, hepatitis B virus, liver surgery
Patrizia Pontisso
Department of Medicine, University of Padua, Padua, Italy.
Research Interests: liver cancer, cirrhosis, diagnostic markers, molecular biology of liver tumors, hepatocellular carcinoma, cholangiocarcinoma
Wenxin Qin
State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Shanghai, China.
Research Interests: molecular mechanism of hepatocarcinogenesis, novel strategies for diagnosis and treatment of hepatocellular carcinoma
Chunfeng Qu
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Research Interests: hepatocellular carcinoma, HBsAg, hepatitis B virus, prevention
Matteo Ravaioli
General Surgery and Transplant Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Research Interests: liver and kidney transplantation, liver resection, hepato-pancreato-biliary surgery, ex-vivo perfusion and regenerative medicine, liver oncology
Lorenza Rimassa
Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Research Interests: hepatocellular carcinoma, biliary tract cancer, cholangiocarcinoma, liver cancer, new drugs, targeted agents, immunotherapy, biomarkers
Andrea RUZZENENTE
Division of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, GB Rossi University Hospital, University of Verona, Verona, Italy.
Research Interests: minimally invasive liver surgery, robotic liver surgery, cholangiocarcinoma
Rodolfo Sacco
Gastroenterology and Digestive Endoscopy Unit, University of Foggia Medical School, Foggia, Italy.
Research Interests: hepatocellular carcinoma, immunotherapy, recurrence hepatocellular carcinoma, cholangiocarcinoma, liver cirrhosis, decompensated liver cirrhosis
Dalbir Singh Sandhu
Department of Gastroenterology and Hepatology, MetroHealth Medical Center/Case Western Reserve University, Cleveland, OH, USA.
Research Interests: liver cancer, biliary cancers, endoscopy
Fuat H. Saner
Department of General, Visceral and Transplantation Surgery, Essen University Medical Center, Essen, Germany.
Research Interests: liver cancer, acute and chronic liver failure, liver transplantation
Robert Schierwagen
Universitätsklinikum Münster, Munster, Germany.
Research Interests: advanced chronic liver diseases and the transition to malignancy, gut-liver axis, hepatocellular carcinoma, circulating biomarkers
Vishal Girishchandra Shelat
Tan Tock Seng Hospital, Singapore City, Singapore.
Research Interests: hepato-pancreatico-biliary surgery, liver resection, hepatocellular carcinoma, robotic hepatobiliary, pancreatic surgery
Bangyan L. Stiles
Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA, USA;
Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Research Interests: molecular biology, carcinogenesis, stem cells, hepatocellular carcinoma
Dar-In Tai
Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan, Taiwan.
Research Interests: hepatitis B virus, genetic polymorphism, hepatocellular carcinoma family, elastography, liver ultrasound
Rolf Teschke
Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Hanau, Germany.
Research Interests: clinical hepatology, DILI, HILI, RUCAM, drugs, herbs, alcohol, aliphatic halogenated hydrocarbons
Pierluigi Toniutto
Hepatology and Liver Transplant Unit, University of Udine, Udine, Italy.
Research Interests: liver cirrhosis, hepatocellular carcinoma, portal hypertension, viral hepatitis, liver transplantation
Christos Triantos
Division of Gastroenterology, Department of Internal Medicine, University Hospital of Patras, Patras, Greece.
Research Interests: hepatocellular carcinoma, liver cirrhosis, viral hepatitis, metabolic dysfunction-associated steatotic liver disease, liver fibrosis
Roberto Ivan Troisi
Division of HPB, Minimally Invasive and Robotic Surgery, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Research Interests: hepatocellular carcinoma, laparoscopic surgery, robotic surgery, robotic donor hepatectomy, liver transplantation, living donor liver transplant
Hong Tu
Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Research Interests: hepatitis B virus-related hepatocellular carcinoma carcinogenesis, hepatocellular carcinoma prediction, hepatocellular carcinoma prevention, tumor marker of hepatocellular carcinoma
Luca Vittorio Carlo Valenti
Internal Medicine and Metabolic Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy;
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milano, Italy.
Research Interests: iron metabolism, iron and metabolic syndrome, metabolic liver diseases, nonalcoholic steatosis hepatitis (NASH), genetics in hepatology, PNPLA3 (patatin-like phospholipase domain-containing protein 3), hepatology, hepatocellular carcinoma, chronic viral hepatitis
Erica Villa
Division of Gastroenterology, University of Modena and Reggio Emilia, Modena, Italy.
Research Interests: hepatitis C virus, cirrhosis, direct-acting antiviral therapy, genotype, hepatitis B virus, platelets, portal hypertension, coagulation
Alessandro Vitale
Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padova, Second General Surgical Unit, Padova Teaching Hospital, Padua, Italy.
Research Interests: hepatocellular carcinoma, liver cancer, hepatobiliary surgery, liver transplantation, MASLD
Cun Wang
State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Research Interests: exploring novel therapeutic strategies for liver cancer, functional genetic screening
Stephen J. Wigmore
Department of Clinical Surgery, University of Edinburgh and Edinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh, UK.
Research Interests: organ transplantation, liver, pancreas, biliary cancer surgery
Carmen Chak-Lui Wong
State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, China.
Research Interests: tumor microenvironment, immunology, metabolism, immunotherapy, precision medicine, hepatocellular carcinoma
Chun-Ming Wong
Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Research Interests: liver cancer genome and epigenome
Rong-Qian Wu
Research Institute of Advanced Surgical Technology and Engineering, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Research Interests: hepatocellular carcinoma, fatty liver disease, liver transplantation, ischemia reperfusion injury
Hong-Ping Xia
School of Basic Medical Sciences & State Key Laboratory of Reproductive Medicine & Key Laboratory of Antibody Technique of National Health Commission & Jiangsu Antibody Drug Engineering Research Center, Nanjing Medical University, Nanjing, Jiangsu, China.
Research Interests: viral and non-viral hepatocellular carcinoma, target therapy, molecular pathology, noncoding RNAs, immunotherapy
Yong-Bing Xiang
Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Research Interests: cancer statistics, cancer epidemiology, survival analysis, meta-analysis, cancer prevention
Qing Xie
Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Research Interests: liver diseases, hepatocellular carcinoma risk evaluation, diagnosis and treatment, immunotherapy of liver cancer. pathogenesis
Jin-Liang Xing
Tumor Markers Committee of China Anti-Cancer Association, Xi’an, Shaanxi, China.
Research Interests: hepatocellular carcinoma, molecular mechanism, circulating cell-free DNA, mtDNA, mitochondria, biomarkers
Fu Yang
Department of Medical Genetics, Second Military Medical University, Shanghai, China.
Research Interests: hepatocellular carcinoma, epigenetics, RNA post-transcriptional modification, tumor energy metabolism, tumor microenvironment, tumor immunity
Xin-Rong Yang
Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
Research Interests: diagnosis and surgical treatment of liver tumours, liver transplantation, clinical and translational research of hepatocellular carcinoma (HCC), liver cancer stem cell, circulating tumor cells
Dengfu Yao
Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
Research Interests: early diagnosis and pathogenesis of hepatocellular carcinoma, hepatocarcinogenesis, biomarkers
Thomas Chung Cheung Yau
Department of Medicine, The University of Hong Kong, Hong Kong, China.
Research Interests: hepatobiliary carcinoma, early phase clinical trials, translational research
Jianhua Yin
Department of Epidemiology, Second Military Medical University, Shanghai, China.
Research Interests: hepatitis B virus, hepatocellular carcinoma, evolution, prediction, prophylaxis, therapeutic option, biomarker
Founding Editor-in-Chief
Joseph F. Buell
Department of Surgery, Mission Health, HCA North Carolina Division, University of North Carolina, Asheville, NC, USA.
All members of the Editorial Board have identified their affiliated institutions or organizations, along with the corresponding country or geographic region. OAE Publishing Inc. remains neutral with regard to any jurisdictional claims.